Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

4-antigen Staphylococcus aureus vaccine - Pfizer

Drug Profile

4-antigen Staphylococcus aureus vaccine - Pfizer

Alternative Names: PF-06290510; PF-6290510; Quadrivan; SA4Ag

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 20 Dec 2018 Pfizer terminates the phase II STRIVE trial in Staphylococcal infections in US, Canada, France, Germany, Spain, Sweden, Hungary, Bulgaria, Austria and the UK
  • 21 Apr 2018 Immunogenicity and safety data from a phase II trial in Staphylococcal infections presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2018)
  • 01 Sep 2016 Pfizer completes a phase II trial in Staphylococcal infections (Prevention) in Japan (IM) (NCT02492958)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top